Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases
Punniyakoti Veeraveedu Thanikachalam, S Ramamurthy, Poojitha Mallapu, Sudhir Varma, Jayaraj Narayanan, Mohammed A. S. Abourehab, Prashant Kesharwani
Topics & Concepts
MAPK/ERK pathwaySignal transductionMedicineInterleukin 33ImmunologyDecoyCytokineLipid signalingInflammationCancer researchCell biologyInterleukinReceptorBiologyInternal medicineIL-33, ST2, and ILC PathwaysEosinophilic Esophagitis